Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending February 2, 2007. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details specific share transfers from the GlaxoSmithKline Employee Trust ("GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991:
- January 31, 2007: Transfer of 4,500 Ordinary Shares.
- February 1, 2007: Transfer of 932 Ordinary Shares.
Three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) are noted as having an interest in the shares held within the GSK Trust, similar to other employees.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the aforementioned share transactions in accordance with Disclosure Rule 3.1.4R(1)(b).
Investor Verification Points
- Confirm the total number of shares transferred from the GSK Trust to the 1991 Employee Share Option Plan (5,432 shares total).
- Verify the specific dates of the transactions (January 31 and February 1, 2007).
- Note that this filing does not impact the company's financial statements or operational outlook.